David Benshoof Klein | CEO
Click Therapeutics | United States

David Benshoof Klein, CEO, Click Therapeutics

David Benshoof Klein is a healthcare investor and entrepreneur with over 15 years life science industry experience; he has played key roles in founding, financing and operating more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics which develops and commercializes software as medical treatments: Digital Therapeutics™. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. He formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein holds a B.A. from Brandeis University and has been a guest lecturer at Columbia University’s Biotechnology Program. A native New Yorker, Mr. Klein is an avid art enthusiast and is co-founder and owner of Klein Sun Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China.

Appearances:



Phar-East Day 2 @ 09:40

Pharma 4:0 Digital disruption: New players, new opportunities

Phar-East Day 2 @ 15:30

Complement or replacement? Envisioning the future of digital therapeutics

last published: 26/Sep/18 02:35 GMT

back to speakers

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738